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Abstract
Introduction: Visceral leishmaniasis is a potentially life-threatening infectious disease which is
caused by parasites of the genus Leishmania and characterized in most cases by the presence of fever
as well as signs and symptoms similar to those found in liver cirrhosis.
Case presentation: In this case report we describe the history of a 50-year-old Caucasian man
incorrectly diagnosed as having hepatitis C virus-associated liver cirrhosis, with a massive weight loss
of around 100 kg during the previous 2 years. However, suspecting a lymphoproliferative disorder,
we were able to make a correct diagnosis of visceral leishmaniasis by bone marrow examination.
After a course of therapy with Liposomal Amphotericin-B the patient recovered and now, 20 months
post-treatment, he is well and has regained a good part of the lost weight.
Conclusions: This case taught us that patients with massive splenomegaly, even with a diagnosis of
liver cirrhosis, should be investigated for infectious or lymphoproliferative diseases.
Introduction
Liver cirrhosis (LC), associated with the hepatitis C virus
(HCV), is very common in the Mediterranean area and is
characterized by enlargement of the liver and spleen and
signs of portal hypertension and pancytopenia, leading to
liver failure or hepatocellular carcinoma [1]. Visceral
leishmaniasis (VL) is an endemic protozoal disease of
the Mediterranean area which, in its chronic course,
presents signs such as liver and spleen enlargement and
pancytopenia that are similar to those found in LC. Here
we report the case of a patient who presented clinically
with these signs, together with serologic anti-HCV
positivity, who had been labeled with a diagnosis of LC
which dramatically masked a picture of progressive VL.
Case presentation
A Sicilian male patient, 50 years of age, was admitted to
our ward for the first time in February 2006 following a
dramatic weight loss (roughly 100 kg) and a presumptive
diagnosis of liver cirrhosis related to hepatitis C virus
(HCV). He was a thalassemia trait carrier and had smoked
20 to 30 cigarettes per day until 6 months previously and
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(around 150 kg), did not indicate any particular problems.
However, following the appearance of asthenia and
abdominal tenderness 6 years ago, laboratory analyses
were performed which showed high serum levels of
alanine aminotransferase (ALT). Liver cirrhosis was
diagnosed on the basis of anti-HCV seropositivity (ELISA
2nd generation) with negative hepatitis B surface antigen
(HBsAg) and the presence of hepato-splenomegaly asso-
ciated with pancytopenia. He had no history of traveling,
alcohol consumption, blood transfusion, jaundice or
anything else of note and, as his HCV-RNA assay was
and remains negative, he has never been treated with
antiviral therapy. He was followed up for many months in
a city hospital and had been receiving therapy with
vitamin K and spironolactone until recently, and he has
never reported having a high temperature.
He presented at our outpatient clinic with asthenia,
fatigue, pedal edema, difficulty in walking, cough, hoarse-
ness and considerable weight loss, which had started
2 years earlier. On physical examination his general
condition was very poor, with loose skin folds, muscle
flabbiness, dryness of the skin and mucosa, mycosis of the
tongue with areas of thickening and massive hepato-
splenomegaly. There was no palpable lymphadenopathy,
spider nevi, palmar erythema or true gynecomastia and a
total blood count performed a few days previously showed
decreased hemoglobin, white blood count (WBC) and
platelets. Ultrasound of the upper abdomen, performed
on the same morning, confirmed massive hepatomegaly
with irregular edges and a non-homogeneous hyperechoic
structure, as well as thin hepatic veins with a flat Doppler
waveform. The portal vein diameter was 1.4 cm (normal ≤
1.2 cm) (Figures 1 and 2). Splenic and superior mesenteric
veins were of normal caliber and showed normal response
to respiration. The gallbladder and biliary tract were
regular and the spleen was enlarged, with a longitudinal
diameter >24 cm and a normal echo pattern. At Doppler,
portal vein mean flow velocity was 37.7 cm/second,
splenic artery resistance index (RI) 0.44 (nv < 0.61) and
pulsatility index (PI) 0.67. There was no ascites but at the
hepatoduodenal ligament there was evidence for the
presence of three oval lymph nodes 2 cm in size; for all
these reasons he was hospitalized.
On admission, hematologic investigations confirmed the
decreased values of hemoglobin (8.8 g/dl), platelets
(66.000/mmc) and WBC (1.270/mmc). Alanine amino
transferase (ALT) and aspartate amino transferase (AST)
were 11 and 15 IU/L; alkaline phosphatase (AP) was
266 IU/L; gamma-glutamyl transferase (gGT) 85 IU/L and
total bilirubin (TB) 0.59 mg/dl. Serum total protein was
7.4 g/dl, (albumin 3.24 g/dl, g-globulin 2.03 g/dl), total
cholesterol 65 mg/dl, INR 1.17, aPTT 32.6 seconds,
fibrinogen 169 mg/dl and a-fetoprotein 0.31 UI/ml. PCR
for HCV-RNA was negative. Electrocardiography and chest
X-ray were normal. Weight was 54.0 kg and height 165 cm.
Because of the very marked weight loss, severe leukopenia
and massive splenomegaly, which are relatively unusual in
the clinical course of liver cirrhosis, and suspecting a
possible lymphomatous progression of the HCV disease,
we consulted a hematologist, who confirmed our suspi-
cions and performed a bone marrow biopsy. The
histologic picture showed a diffuse or nodular aggregation
of histiocytic hyperplasia, containing within the cytoplasm
many elements referable to the genus Leishmania
Figure 1. Dilated portal vein and an increased antero-
posterior diameter of the liver.
Figure 2. Thin right hepatic vein and an increased
antero-posterior diameter of the liver.
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performed with indirect immunofluorescence revealed a
IgG titre of 1/400. HCV-RNA, performed during hospita-
lization with RT-PCR was negative and serum levels of
both aminotransferases were always within normal limits.
To verify the presence of an immunodepressive status
lymphocyte typing was performed, revealing a consider-
able reduction in B lymphocytes and an inversion of the
CD4/CD8 ratio. HIV serology was negative. The patient
therefore underwent a course of therapy with liposomal
amphotericin-B (AmBisome) at a dose of 3 mg/kg per day
on days 1 to 5, day 14 and day 21.
He was discharged at the end of February in relatively good
general health and invited to continue therapy at home
with spironolactone 100 mg/day and mycostatin half
dropper four times per day for 15 days and advised a
periodic outpatient check-up at our hospital.
During this time his general condition slowly but
progressively improved. Liver function tests remained
stable as did nutritional indexes. The patient gained
weight, started to walk normally again and has now
returned to almost normal activity, including a gradual
return to work. Following the improvement in his clinical
condition we performed a laboratory reappraisal. Oeso-
phagogastroduodenoscopy showed hyperemic gastritis
without esophageal varices. Abdominal ultrasound (US)
showed hepatomegaly and splenomegaly with a longi-
tudinal diameter of 18 cm. At Doppler the same
parameters as above were confirmed. His weight was
84.5 kg, height 165 cm, BP 125/80 mmHg, PR 82/m, ALT
and AST within the normal range, albumin 3.6 g/L,
g-globulin 1.56 g/dl, total cholesterol 132 mg/dl and aPTT
29 seconds. As HCV-RNA remained negative, we retested
anti-HCV using a third generation method with a negative
result. At this point, the initial diagnosis of liver cirrhosis,
even as a disease underlying VL, seemed improbable. On
the other hand, the hypothesis of a masking of a pathology
that from the beginning could have been VL, albeit with
some atypical tracts, is gaining significance. The patient is
at present being followed-up and is on support therapy,
which includes psychological support and alimentary
education training following a diet with oligo elements
and vitamin supplements under the supervision of a
nutritionist.
Discussion
Leishmaniasis is a parasitic disease transmitted by the bite
of sand flies. Three main forms are known: cutaneous,
mucocutaneous and visceral. VL presents a sub-acute or
chronic course and if not treated with a specific therapy the
disease almost invariably leads to terminal cachexia and
death [2]. The case we observed is interesting because a
number of considerations can be made. First of all, the
presence of anti-HCV positivity, together with hypertrans-
aminasemia and liver and spleen enlargement, led to a
diagnosis of HCV-related liver cirrhosis but the negative
viremia associated with pancytopenia ruled out the need
for a cycle of antiviral therapy.
The possibility of mistaking a chronic liver disease for VL
has been recently reported in the literature [3]. Prakash
et al presented the case of a patient with clinical and
biochemical features of liver cirrhosis in whom a correct
diagnosis of VL was made after liver biopsy, which
demonstrated the parasite in the Kupffer cells. Unfortu-
nately, the patient died after commencing therapy with
sodium antimony stibogluconate [3]. Acute hepatitis has
also been reported as a presenting manifestation of VL [4].
In our case, another feature which delayed the correct
diagnosis was the constant absence of fever in spite of the
lengthy duration of the illness, although it is well known
that VL is usually associated with fever. This event,
although rare, has also been reported by other authors
[5], but a lack of this fundamental symptom can obviously
delay or divert from a correct diagnosis. Another compo-
nent that most likely contributed to the misdiagnosis was
weight loss. Since thepatient was severely obese, his loss in
weight, at least initially, was seen as a positive factor for his
health, but obviously not when this went beyond normal
limits.
Moreover a certain carelessness on the part of the patient
about his condition and the presence of the anti-HCV
positivity, contributed to delaying the true diagnosis.
Even in our clinic the diagnosis of VL was made by
chance, because our initial suspicion was a possible
Figure 3. Leishmania amastigotes inside phagocytic cells
(arrows), on bone marrow biopsy, in the form of round
cytoplasmic inclusions. (Giemsa, original magnification X 400).
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spleen, which were too large in volume for a common
HCV-associated LC. This orientation was based on a recent
case of ours of lymphomatous liver in a HCV-positive
patient, which had luckily been identified [6]. Therefore,
we were surprised to identify leishmania in the bone
marrow and the diagnosis was confirmed both with
serology and a successful course of specific therapy.
Naturally, some of the data obtained were not in
agreement with a diagnosis of liver cirrhosis, including
the lack of portal hypertension at ultrasound using color-
Doppler, as well as the lack of oesophageal varices at
endoscopy. We consequently investigated for the presence
of an underlying HCV-associated chronic liver disease
(CLD). HCV-RNA assay, repeated during the course of the
disease, was always negative and the re-evaluation of anti-
HCV positivity, using a third generation assay (ELISA 3),
was also negative, so there was probably no underlying
CLD. Indeed, the anti-HCV positivity, although it was
performed using a second generation assay, may be seen as
a falsepositive result due to hypergamma globulinemia or,
more specifically, linked to the production of IgM with
rheumatoid factor (RF) characteristics. In fact, it has been
reported that an increase in IgM-RF production is an
autoimmune characteristic of VL [7] and it is well known
that the presence of RF could interfere with correct anti-
HCV detection, causing significant false positive reactivity
[8]. Unfortunately, we did not perform RF before
treatment and now RF is negative, so our suggestion
remains speculative. Another possibility is that some
antigens of leishmania may have a cross reaction with
HCV, but this hypothesis needs further investigation.
Confirmation of a possible chronic liver disease should be
performed by liver biopsy, but at the moment we consider
it unethical and unnecessary to perform an invasive
investigation, both because the patient is unwilling and
there are also no indications for alternative treatment.
Conclusions
Here we report the case of a patient with massive weight
loss, severe hepato- and splenomegaly, pancytopenia and
anti-HCV positivity, who had been labeled as cirrhotic. The
diagnosis of VL, made by chance, allowed us to give the
patient specific treatment, without which he would most
probably have died. This experience should induce physi-
cians to further investigate and, if necessary, re-evaluate a
given diagnosis (in this specific case liver cirrhosis, whether
it is of viral or non-viral origin), when its course or clinical
signs deviate from the current standard diagnostic criteria.
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